Alane T. Koki
Impact in
- Pharmacology top 0.1%
- Inflammatory mediators and NSAID effects
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 31
- Inflammatory mediators and NSAID effects 31
- Pharmacogenetics and Drug Metabolism 2
- Genetics 21
- Estrogen and related hormone effects 21
- Co-authors
- Jaime L. Masferrer (22 shared papers)B. Mark Woerner (10 shared papers)Kathleen M. Leahy (8 shared papers)Andrew J. Dannenberg (6 shared papers)Karen Seibert (8 shared papers)Robert A. Soslow (5 shared papers)Ben S. Zweifel (5 shared papers)Kanwar Nasir M. Khan (5 shared papers)
- Journals
- Molecular Carcinogenesis (2 papers)Advances in experimental medicine and biology (2 papers)Oncogene (2 papers)Current Medicinal Chemistry (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Alane T. Koki
38 papers receiving 6.1k citations
Alane T. Koki's Hit Papers
Peers
Comparison fields: 5 of 119
- Pharmacology 3.5k
- Biochemistry 542
- Genetics 1.8k
- Cancer Research 878
- Psychiatry and Mental health 822
Countries citing papers authored by Alane T. Koki
This map shows the geographic impact of Alane T. Koki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alane T. Koki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alane T. Koki more than expected).
Fields of papers citing papers by Alane T. Koki
This network shows the impact of papers produced by Alane T. Koki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alane T. Koki. The network helps show where Alane T. Koki may publish in the future.
Co-authors
The 25 scholars most cited alongside Alane T. Koki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Hit paper breakdown → | 2000 | 1153 |
| 2 | COX-2 is expressed in human pulmonary, colonic, and mammary tumors Hit paper breakdown → | 2000 | 774 |
| 3 | Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Hit paper breakdown → | 1999 | 636 |
| 4 | Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Hit paper breakdown → | 1999 | 623 |
| 5 | Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. | 2002 | 387 |
| 6 | Cyclooxygenase-2 is overexpressed in human cervical cancer. | 2001 | 300 |
| 7 | 2002 | 279 | |
| 8 | Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. | 1999 | 255 |
| 9 | Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. | 2000 | 237 |
| 10 | 2002 | 201 | |
| 11 | 2005 | 182 | |
| 12 | 1998 | 178 | |
| 13 | 2000 | 167 | |
| 14 | 2003 | 141 | |
| 15 | 1999 | 140 | |
| 16 | 2002 | 119 | |
| 17 | 1999 | 109 | |
| 18 | 2004 | 106 | |
| 19 | Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. | 2002 | 63 |
| 20 | 2001 | 60 |
About Alane T. Koki
Alane T. Koki is a scholar working on Pharmacology, Genetics, Psychiatry and Mental health, Biochemistry and Cancer Research, having authored 38 papers that have together received 6.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (31 papers), Estrogen and related hormone effects (21 papers), Cancer, Stress, Anesthesia, and Immune Response (12 papers), Eicosanoids and Hypertension Pharmacology (7 papers), Pharmacogenetics and Drug Metabolism (2 papers), Lipoproteins and Cardiovascular Health (1 paper), Preterm Birth and Chorioamnionitis (1 paper) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Pharmacology (3.5k citations), Biochemistry (542 citations), Genetics (1.8k citations), Cancer Research (878 citations) and Psychiatry and Mental health (822 citations). Alane T. Koki has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Jaime L. Masferrer, B. Mark Woerner, Kathleen M. Leahy, Andrew J. Dannenberg, Karen Seibert, Robert A. Soslow, Ben S. Zweifel, Kanwar Nasir M. Khan, D A Edwards and Steven L. Settle. Their work appears in journals such as Molecular Carcinogenesis, Advances in experimental medicine and biology, Oncogene, Current Medicinal Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.